Fujisawa, Japan

Tadashi Umemoto



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Kanagawa, JP (2014)
  • Fujisawa, JP (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tadashi Umemoto

Introduction

Tadashi Umemoto is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of nucleic acids, holding 2 patents that showcase his innovative approach to genetic diagnostics and therapeutic methods.

Latest Patents

One of his latest patents is focused on a modified nucleic acid. This invention provides an oligonucleic acid analog that includes a modified nucleic acid monomer compound. This compound features a ring-open nucleoside with a cleaved carbon-carbon bond between the 2' and 3' positions, along with a substituent hydroxymethyl group at the 4' position. When utilized as siRNA, this oligonucleic acid analog demonstrates superior biological stability and effective target gene expression inhibition. It has versatile applications, including antisense methods, ribozyme methods, and decoy methods. Additionally, it can serve as a nucleic acid aptamer, a nucleic acid probe, or a molecular beacon, and is applicable in genetic diagnostics.

Another significant patent by Umemoto addresses the process for producing nucleosides. This invention responds to the demand for a convenient production method of an NC type purine nucleoside. The method involves reacting a pyrimidine nucleoside with a purine nucleobase in the presence of a Lewis acid, leading to the production of a purine nucleoside or its salt.

Career Highlights

Tadashi Umemoto is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research and innovations in the field of pharmaceuticals and biotechnology.

Collaborations

He has collaborated with notable colleagues such as Shumpei Murata and Yoji Hayase, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tadashi Umemoto's work in the field of nucleic acids exemplifies the impact of innovative thinking in biotechnology. His patents not only enhance our understanding of genetic materials but also pave the way for future advancements in medical diagnostics and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…